Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Acadia Pharmaceuticals Inc shares valued at $9,481 were sold by Kihara James on Feb 24 ’25. At $19.96 per share, Kihara James sold 475 shares. The insider’s holdings dropped to 20,228 shares worth approximately $0.39 million following the completion of this transaction.
Also, Schneyer Mark C. sold 773 shares, netting a total of over 15,429 in proceeds. Following the sale of shares at $19.96 each, the insider now holds 53,882 shares.
Before that, Teehan Brendan had sold 10,329 shares from its account. In a trade valued at $173,630, the EVP, COO, HEAD OF COMMERCIAL traded Acadia Pharmaceuticals Inc shares for $16.81 each. Upon closing the transaction, the insider’s holdings decreased to 10,329 shares, worth approximately $1.2 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Acadia Pharmaceuticals Inc [ACAD] has been a Hold and the price target has been revised to $22. Analysts at Guggenheim downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. Earlier on August 07, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for ACAD stock which previously was a “an Overweight”.
Analyzing ACAD Stock Performance
During the last five days, there has been a drop of approximately -4.68%. Over the course of the year, Acadia Pharmaceuticals Inc shares have jumped approximately 5.40%. Shares of the company reached a 52-week high of $20.68 on 02/21/25 and a 52-week low of $16.61 on 01/14/25. A 50-day SMA is recorded $18.27, while a 200-day SMA reached $16.63.
Support And Resistance Levels for Acadia Pharmaceuticals Inc (ACAD)
According to the 24-hour chart, there is a support level at 18.57, which, if violated, would cause prices to drop to 17.81. In the upper region, resistance lies at 20.36. The next price resistance is at 21.39. RSI (Relative Strength Index) is 53.72 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.26, which suggests the price will decrease in the coming days. Percent R is at 52.14%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
